155 related articles for article (PubMed ID: 28490612)
1. Pathology update to the Manchester Scoring System based on testing in over 4000 families.
Evans DG; Harkness EF; Plaskocinska I; Wallace AJ; Clancy T; Woodward ER; Howell TA; Tischkowitz M; Lalloo F
J Med Genet; 2017 Oct; 54(10):674-681. PubMed ID: 28490612
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.
Kast K; Schmutzler RK; Rhiem K; Kiechle M; Fischer C; Niederacher D; Arnold N; Grimm T; Speiser D; Schlegelberger B; Varga D; Horvath J; Beer M; Briest S; Meindl A; Engel C
Int J Cancer; 2014 Nov; 135(10):2352-61. PubMed ID: 24700448
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting
Chew W; Moorakonda RB; Courtney E; Soh H; Li ST; Chen Y; Shaw T; Allen JC; Evans DGR; Ngeow J
J Med Genet; 2018 May; 55(5):344-350. PubMed ID: 29275357
[TBL] [Abstract][Full Text] [Related]
4. Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
Antoniou AC; Hardy R; Walker L; Evans DG; Shenton A; Eeles R; Shanley S; Pichert G; Izatt L; Rose S; Douglas F; Eccles D; Morrison PJ; Scott J; Zimmern RL; Easton DF; Pharoah PD
J Med Genet; 2008 Jul; 45(7):425-31. PubMed ID: 18413374
[TBL] [Abstract][Full Text] [Related]
5. Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.
Evans DG; Woodward ER; Howell SJ; Verhoef S; Howell A; Lalloo F
Fam Cancer; 2017 Apr; 16(2):173-179. PubMed ID: 27796713
[TBL] [Abstract][Full Text] [Related]
6. Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.
Evans DG; Lalloo F; Cramer A; Jones EA; Knox F; Amir E; Howell A
J Med Genet; 2009 Dec; 46(12):811-7. PubMed ID: 19542080
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
Thirthagiri E; Lee SY; Kang P; Lee DS; Toh GT; Selamat S; Yoon SY; Taib NA; Thong MK; Yip CH; Teo SH
Breast Cancer Res; 2008; 10(4):R59. PubMed ID: 18627636
[TBL] [Abstract][Full Text] [Related]
8. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
9. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Mavaddat N; Barrowdale D; Andrulis IL; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Spurdle A; Robson M; Sherman M; Mulligan AM; Couch FJ; Engel C; McGuffog L; Healey S; Sinilnikova OM; Southey MC; Terry MB; Goldgar D; O'Malley F; John EM; Janavicius R; Tihomirova L; Hansen TV; Nielsen FC; Osorio A; Stavropoulou A; Benítez J; Manoukian S; Peissel B; Barile M; Volorio S; Pasini B; Dolcetti R; Putignano AL; Ottini L; Radice P; Hamann U; Rashid MU; Hogervorst FB; Kriege M; van der Luijt RB; ; Peock S; Frost D; Evans DG; Brewer C; Walker L; Rogers MT; Side LE; Houghton C; ; Weaver J; Godwin AK; Schmutzler RK; Wappenschmidt B; Meindl A; Kast K; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Varon-Mateeva R; Schönbuchner I; Gevensleben H; Stoppa-Lyonnet D; Belotti M; Barjhoux L; ; Isaacs C; Peshkin BN; Caldes T; de la Hoya M; Cañadas C; Heikkinen T; Heikkilä P; Aittomäki K; Blanco I; Lazaro C; Brunet J; Agnarsson BA; Arason A; Barkardottir RB; Dumont M; Simard J; Montagna M; Agata S; D'Andrea E; Yan M; Fox S; ; Rebbeck TR; Rubinstein W; Tung N; Garber JE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet MM; Singer CF; Tea MK; Rappaport C; Mai PL; Greene MH; Sokolenko A; Imyanitov E; Toland AE; Senter L; Sweet K; Thomassen M; Gerdes AM; Kruse T; Caligo M; Aretini P; Rantala J; von Wachenfeld A; Henriksson K; ; Steele L; Neuhausen SL; Nussbaum R; Beattie M; Odunsi K; Sucheston L; Gayther SA; Nathanson K; Gross J; Walsh C; Karlan B; Chenevix-Trench G; Easton DF; Antoniou AC;
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):134-47. PubMed ID: 22144499
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer.
Rybchenko LA; Bychkova AM; Skyban GV; Klymenko SV
Probl Radiac Med Radiobiol; 2013; (18):253-60. PubMed ID: 25191729
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.
Simard J; Dumont M; Moisan AM; Gaborieau V; Malouin H; Durocher F; Chiquette J; Plante M; Avard D; Bessette P; Brousseau C; Dorval M; Godard B; Houde L; ; Joly Y; Lajoie MA; Leblanc G; Lépine J; Lespérance B; Vézina H; Parboosingh J; Pichette R; Provencher L; Rhéaume J; Sinnett D; Samson C; Simard JC; Tranchant M; Voyer P; Easton D; Tavtigian SV; Knoppers BM; Laframboise R; Bridge P; Goldgar D
J Med Genet; 2007 Feb; 44(2):107-21. PubMed ID: 16905680
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
13. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
14. [A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition].
Bonaïti B; Alarcon F; Bonadona V; Pennec S; Andrieu N; Stoppa-Lyonnet D; Perdry H; Bonaïti-Pellié C;
Bull Cancer; 2011 Jul; 98(7):779-95. PubMed ID: 21708517
[TBL] [Abstract][Full Text] [Related]
15. A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening.
Bonaïti B; Alarcon F; Andrieu N; Bonadona V; Dondon MG; Pennec S; Stoppa-Lyonnet D; Bonaïti-Pellié C; Perdry H
J Med Genet; 2014 Feb; 51(2):114-21. PubMed ID: 24343917
[TBL] [Abstract][Full Text] [Related]
16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of women with genomic BRCA1 and BRCA2 mutations.
Chang J; Elledge RM
Breast Cancer Res Treat; 2001 Sep; 69(2):101-13. PubMed ID: 11759816
[TBL] [Abstract][Full Text] [Related]
18. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
Evans DG; Lalloo F; Wallace A; Rahman N
J Med Genet; 2005 Jul; 42(7):e39. PubMed ID: 15994864
[No Abstract] [Full Text] [Related]
19. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
Evans DG; Eccles DM; Rahman N; Young K; Bulman M; Amir E; Shenton A; Howell A; Lalloo F
J Med Genet; 2004 Jun; 41(6):474-80. PubMed ID: 15173236
[TBL] [Abstract][Full Text] [Related]
20. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
James PA; Doherty R; Harris M; Mukesh BN; Milner A; Young MA; Scott C
J Clin Oncol; 2006 Feb; 24(4):707-15. PubMed ID: 16446345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
